We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
XBiotech
XBIT
$69.2M
| $1.37M | ﹤0.01% |
73,222
+15,547
| +27% | +$200K |
|
2577
Napco Security Technologies
NSSC
$1.48B
| $1.35M | ﹤0.01% |
92,100
+2,094
| +2% | +$30.4K |
|
2578
Teekay
TK
$985M
| $1.35M | ﹤0.01% |
253,348
-14,916
| -6% | -$73.8K |
|
|
BFIN
2579
DELISTED
BankFinancial
BFIN
| $1.34M | ﹤0.01% |
102,712
| – | – |
|
2580
Takeda Pharmaceutical
TAK
$55.7B
| $1.34M | ﹤0.01% |
67,708
| – | – |
|
2581
Construction Partners
ROAD
$6.77B
| $1.33M | ﹤0.01% |
79,063
+21,221
| +37% | +$373K |
|
2582
Rigel Pharmaceuticals
RIGL
$750M
| $1.33M | ﹤0.01% |
62,240
| – | – |
|
2583
Citizens
CIA
$192M
| $1.32M | ﹤0.01% |
195,915
-2,371
| -1% | -$16.3K |
|
2584
Donnelley Financial Solutions
DFIN
$1.16B
| $1.32M | ﹤0.01% |
126,137
+1,205
| +1% | +$12.6K |
|
2585
Antero Resources
AR
$10.7B
| $1.32M | ﹤0.01% |
463,292
-87,024
| -16% | -$222K |
|
2586
Daktronics
DAKT
$1.04B
| $1.32M | ﹤0.01% |
216,529
+575
| +0.3% | +$3.84K |
|
|
HTT
2587
High Templar Tech Ltd
HTT
$391M
| $1.31M | ﹤0.01% |
+279,000
| New | +$1.64M |
|
2588
Ardelyx
ARDX
$997M
| $1.31M | ﹤0.01% |
174,395
-336,362
| -66% | -$2.04M |
|
2589
Genco Shipping & Trading
GNK
$1.1B
| $1.31M | ﹤0.01% |
123,065
-171,687
| -58% | -$1.77M |
|
|
MEET
2590
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $1.31M | ﹤0.01% |
261,039
-15,585
| -6% | -$73.3K |
|
2591
Winmark
WINA
$1.32B
| $1.31M | ﹤0.01% |
6,588
-4,468
| -40% | -$805K |
|
2592
NN Inc
NNBR
$311M
| $1.3M | ﹤0.01% |
140,259
-7,722
| -5% | -$62K |
|
2593
Turning Point Brands
TPB
$1.74B
| $1.29M | ﹤0.01% |
45,079
-27,700
| -38% | -$694K |
|
2594
Park Aerospace
PKE
$819M
| $1.29M | ﹤0.01% |
79,190
-24,986
| -24% | -$414K |
|
|
AMK
2595
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $1.28M | ﹤0.01% |
44,261
-75
| -0.2% | -$1.96K |
|
|
ORC
2596
Orchid Island Capital
ORC
$1.31B
| $1.28M | ﹤0.01% |
43,826
+515
| +1% | +$14.8K |
|
2597
Future Fuel
FF
$223M
| $1.27M | ﹤0.01% |
102,780
| – | – |
|
2598
Foster
FSTR
$432M
| $1.27M | ﹤0.01% |
65,640
| – | – |
|
2599
Accuray
ARAY
$34M
| $1.27M | ﹤0.01% |
450,098
-254,288
| -36% | -$706K |
|
2600
Greenlight Captial
GLRE
$506M
| $1.26M | ﹤0.01% |
124,948
-6,973
| -5% | -$72.2K |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.